BiologicsMD Uses Unique Fusion Proteins To Treat Alopecia Safely

Emerging Company Profile: The US biotech is developing a series of recombinant fusion proteins to tackle alopecia and other diseases without supressing the immune system.    

Emerging Company Profile: BiologicsMD
Alopecia Can Have Many Difference Causes • Source: Shutterstock

BiologicsMD Inc’s recombinant fusion protein approach could show greater precision and fewer off-target effects while addressing latent unmet need in hair and bone conditions.

While the firm’s programs are currently in preclinical development, it is raising a financing round with an eye to starting...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Emerging Company Profiles

More from Start-Ups & SMEs